Shares of Arena Pharmaceuticals fell 5.61% to $76.66 at 16:40 EST on Thursday, after two consecutive sessions in a row of gains. NASDAQ Composite is jumping 0.55% to $13,530.92, after two sequential sessions in a row of gains. This seems, up until now, a somewhat positive trend trading session today.

Arena Pharmaceuticals’s last close was $81.22, 17.65% below its 52-week high of $90.19.

Arena Pharmaceuticals’s Sales

Arena Pharmaceuticals’s sales growth is a negative 81.3% for the ongoing quarter and 155.7% for the next. The company’s growth estimates for the current quarter is a negative 4.5% and positive 4.5% for the next.

Arena Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 98.5%, now sitting on 3.28M for the twelve trailing months.


Arena Pharmaceuticals’s last day, last week, and last month’s average volatility was 0.64%, 1.08%, and 0.56%, respectively.

Arena Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 1.76%, 4.20%, and 3.86%, respectively.

Arena Pharmaceuticals’s Stock Yearly Top and Bottom Value

Arena Pharmaceuticals’s stock is valued at $76.66 at 16:40 EST, way under its 52-week high of $90.19 and way higher than its 52-week low of $32.95.

Arena Pharmaceuticals’s Moving Average

Arena Pharmaceuticals’s value is above its 50-day moving average of $74.18 and above its 200-day moving average of $71.54.


Please enter your comment!
Please enter your name here